Atlas Trials

An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic Patients

Clinical trial NCT02555709 · COMPLETED

Trial details

NCT number
NCT02555709
Sponsor
Vitae Pharmaceuticals Inc., an Allergan affiliate
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Psoriasis
Start date
2015-08-01
Primary completion
2016-03-01
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.